Blockade of receptor for advanced glycation endproducts: A new target for therapeutic intervention in diabetic complications and inflammatory disorders

Barry I. Hudson, Loredana G. Bucciarelli, Thoralf Wendt, Taichi Sakaguchi, Evanthia Lalla, Wu Qu, Yan Lu, Larisse Lee, David Stern, Yoshifumi Naka, Ravichandran Ramasamy, Shi Du Yan, Shi Fang Yan, Vivette D'Agati, Ann Marie Schmidt

Research output: Contribution to journalReview article

141 Citations (Scopus)

Abstract

The glycation and oxidation of proteins/lipids leads to the generation of a new class of biologically active moieties, the advanced glycation endproducts (AGEs). Recent studies have elucidated that carboxymethyllysine (CML) adducts of proteins/lipids are a highly prevalent AGE in vivo. CML-modified adducts are signal transduction ligands of the receptor for AGE (RAGE), a member of the immunoglobulin superfamily. Importantly, CML-modified adducts accumulate in diverse settings. In addition to enhanced formation in settings of high glucose, these adducts form in inflammatory milieu. Studies performed both in vitro and in vivo have suggested that the proinflammatory/tissue destructive consequences of RAGE activation in the diabetic/inflamed environment may be markedly attenuated by blockade of the ligand-RAGE axis. Here, we will summarize the known consequences of RAGE activation in the tissues and highlight novel areas for therapeutic intervention in these disease states.

Original languageEnglish (US)
Pages (from-to)80-88
Number of pages9
JournalArchives of Biochemistry and Biophysics
Volume419
Issue number1
DOIs
StatePublished - Nov 1 2003

Fingerprint

Diabetes Complications
Chemical activation
Tissue
Ligands
Lipids
Signal transduction
Therapeutics
Immunoglobulins
Signal Transduction
Proteins
Glucose
Oxidation
Advanced Glycosylation End Product-Specific Receptor
N(6)-carboxymethyllysine

All Science Journal Classification (ASJC) codes

  • Biophysics
  • Biochemistry
  • Molecular Biology

Cite this

Blockade of receptor for advanced glycation endproducts : A new target for therapeutic intervention in diabetic complications and inflammatory disorders. / Hudson, Barry I.; Bucciarelli, Loredana G.; Wendt, Thoralf; Sakaguchi, Taichi; Lalla, Evanthia; Qu, Wu; Lu, Yan; Lee, Larisse; Stern, David; Naka, Yoshifumi; Ramasamy, Ravichandran; Yan, Shi Du; Yan, Shi Fang; D'Agati, Vivette; Schmidt, Ann Marie.

In: Archives of Biochemistry and Biophysics, Vol. 419, No. 1, 01.11.2003, p. 80-88.

Research output: Contribution to journalReview article

Hudson, BI, Bucciarelli, LG, Wendt, T, Sakaguchi, T, Lalla, E, Qu, W, Lu, Y, Lee, L, Stern, D, Naka, Y, Ramasamy, R, Yan, SD, Yan, SF, D'Agati, V & Schmidt, AM 2003, 'Blockade of receptor for advanced glycation endproducts: A new target for therapeutic intervention in diabetic complications and inflammatory disorders', Archives of Biochemistry and Biophysics, vol. 419, no. 1, pp. 80-88. https://doi.org/10.1016/j.abb.2003.08.030
Hudson, Barry I. ; Bucciarelli, Loredana G. ; Wendt, Thoralf ; Sakaguchi, Taichi ; Lalla, Evanthia ; Qu, Wu ; Lu, Yan ; Lee, Larisse ; Stern, David ; Naka, Yoshifumi ; Ramasamy, Ravichandran ; Yan, Shi Du ; Yan, Shi Fang ; D'Agati, Vivette ; Schmidt, Ann Marie. / Blockade of receptor for advanced glycation endproducts : A new target for therapeutic intervention in diabetic complications and inflammatory disorders. In: Archives of Biochemistry and Biophysics. 2003 ; Vol. 419, No. 1. pp. 80-88.
@article{3af4426572534d8db1a91ac465a9884c,
title = "Blockade of receptor for advanced glycation endproducts: A new target for therapeutic intervention in diabetic complications and inflammatory disorders",
abstract = "The glycation and oxidation of proteins/lipids leads to the generation of a new class of biologically active moieties, the advanced glycation endproducts (AGEs). Recent studies have elucidated that carboxymethyllysine (CML) adducts of proteins/lipids are a highly prevalent AGE in vivo. CML-modified adducts are signal transduction ligands of the receptor for AGE (RAGE), a member of the immunoglobulin superfamily. Importantly, CML-modified adducts accumulate in diverse settings. In addition to enhanced formation in settings of high glucose, these adducts form in inflammatory milieu. Studies performed both in vitro and in vivo have suggested that the proinflammatory/tissue destructive consequences of RAGE activation in the diabetic/inflamed environment may be markedly attenuated by blockade of the ligand-RAGE axis. Here, we will summarize the known consequences of RAGE activation in the tissues and highlight novel areas for therapeutic intervention in these disease states.",
author = "Hudson, {Barry I.} and Bucciarelli, {Loredana G.} and Thoralf Wendt and Taichi Sakaguchi and Evanthia Lalla and Wu Qu and Yan Lu and Larisse Lee and David Stern and Yoshifumi Naka and Ravichandran Ramasamy and Yan, {Shi Du} and Yan, {Shi Fang} and Vivette D'Agati and Schmidt, {Ann Marie}",
year = "2003",
month = "11",
day = "1",
doi = "10.1016/j.abb.2003.08.030",
language = "English (US)",
volume = "419",
pages = "80--88",
journal = "Archives of Biochemistry and Biophysics",
issn = "0003-9861",
publisher = "Academic Press Inc.",
number = "1",

}

TY - JOUR

T1 - Blockade of receptor for advanced glycation endproducts

T2 - A new target for therapeutic intervention in diabetic complications and inflammatory disorders

AU - Hudson, Barry I.

AU - Bucciarelli, Loredana G.

AU - Wendt, Thoralf

AU - Sakaguchi, Taichi

AU - Lalla, Evanthia

AU - Qu, Wu

AU - Lu, Yan

AU - Lee, Larisse

AU - Stern, David

AU - Naka, Yoshifumi

AU - Ramasamy, Ravichandran

AU - Yan, Shi Du

AU - Yan, Shi Fang

AU - D'Agati, Vivette

AU - Schmidt, Ann Marie

PY - 2003/11/1

Y1 - 2003/11/1

N2 - The glycation and oxidation of proteins/lipids leads to the generation of a new class of biologically active moieties, the advanced glycation endproducts (AGEs). Recent studies have elucidated that carboxymethyllysine (CML) adducts of proteins/lipids are a highly prevalent AGE in vivo. CML-modified adducts are signal transduction ligands of the receptor for AGE (RAGE), a member of the immunoglobulin superfamily. Importantly, CML-modified adducts accumulate in diverse settings. In addition to enhanced formation in settings of high glucose, these adducts form in inflammatory milieu. Studies performed both in vitro and in vivo have suggested that the proinflammatory/tissue destructive consequences of RAGE activation in the diabetic/inflamed environment may be markedly attenuated by blockade of the ligand-RAGE axis. Here, we will summarize the known consequences of RAGE activation in the tissues and highlight novel areas for therapeutic intervention in these disease states.

AB - The glycation and oxidation of proteins/lipids leads to the generation of a new class of biologically active moieties, the advanced glycation endproducts (AGEs). Recent studies have elucidated that carboxymethyllysine (CML) adducts of proteins/lipids are a highly prevalent AGE in vivo. CML-modified adducts are signal transduction ligands of the receptor for AGE (RAGE), a member of the immunoglobulin superfamily. Importantly, CML-modified adducts accumulate in diverse settings. In addition to enhanced formation in settings of high glucose, these adducts form in inflammatory milieu. Studies performed both in vitro and in vivo have suggested that the proinflammatory/tissue destructive consequences of RAGE activation in the diabetic/inflamed environment may be markedly attenuated by blockade of the ligand-RAGE axis. Here, we will summarize the known consequences of RAGE activation in the tissues and highlight novel areas for therapeutic intervention in these disease states.

UR - http://www.scopus.com/inward/record.url?scp=0142089894&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0142089894&partnerID=8YFLogxK

U2 - 10.1016/j.abb.2003.08.030

DO - 10.1016/j.abb.2003.08.030

M3 - Review article

C2 - 14568011

AN - SCOPUS:0142089894

VL - 419

SP - 80

EP - 88

JO - Archives of Biochemistry and Biophysics

JF - Archives of Biochemistry and Biophysics

SN - 0003-9861

IS - 1

ER -